Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Lazzerini PE, Capperucci C, Spreafico A, Capecchi PL, Niccolini S, Ferrata P, et al
Clinical Status Human RCT | Observational | Animal | In vitro Primarily studied in preclinical anabolic and metabolic research contexts, with limited exploratory human data
The market is segmented by product type, application, and end-user channel and region
Adverse Effects Profile (Phase 2 Data) The Phase 2 NEJM 2023 trial reported the following adverse event profile
US$ 28.20
US$ 20.40
US$ 26.34
